Viewing Study NCT03906292


Ignite Creation Date: 2025-12-24 @ 3:43 PM
Ignite Modification Date: 2025-12-25 @ 1:51 PM
Study NCT ID: NCT03906292
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-10
First Post: 2018-12-14
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Frontline Asciminib Combination in Chronic Phase CML
Sponsor: University of Jena
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module